Targeting VAMPs in Aging-Related Diseases: From Mechanisms to Pharmacotherapy
- 20 May 2026
- journal article
- review article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 43 (6) , 1915-1933
Abstract
Vesicle-associated membrane proteins (VAMPs) are key regulators of membrane fusion, vesicular trafficking and intercellular communication. Structurally and functionally diverse, VAMPs participate in multiple physiological processes, and their dysfunction facilitates the progression of various aging-related diseases. This review aims to systematically summarize the molecular mechanisms and therapeutic potential of VAMPs. We summarize current evidence to clarify the functions of VAMPs in aging-related disorders, and elaborate their roles in vesicle dynamic events as well as the regulatory effects of post-translational modifications on VAMP activity. VAMPs are closely involved in neurodegenerative, metabolic, cardiovascular diseases and cancers. They modulate the whole process of vesicle circulation, and post-translational modifications dynamically regulate VAMP function. VAMP-targeting agents present promising prospects for disease intervention. Targeting VAMPs provides innovative therapeutic strategies to ameliorate aging-related pathological conditions.Keywords
Funding Information
- Natural Science Foundation of Tianjin, China (24JCZDJC00570)
- Young Faculty’s Research and Innovation Capability Development in Tianjin Higher Education Institutions Initiated by the Ministry of Education
- National Natural Science Foundation of China (82274221)
- National Natural Science Foundation of China (82104461)
- Graduate Research Innovation Project of TUTCM, Tianjin, China (YJSKC-20240035)
This publication has 128 references indexed in Scilit:
- Inhibition of mTOR prevents glucotoxicity-mediated increase of SA-beta-gal, p16INK4a, and insulin hypersecretion, without restoring electrical features of mouse pancreatic isletsBiogerontology, 2024
- Inhibition of STX17–SNAP29–VAMP8 complex formation by costunolide sensitizes ovarian cancer cells to cisplatin via the AMPK/mTOR signaling pathwayBiochemical Pharmacology, 2023
- Release of VAMP5‐positive extracellular vesicles by retinal Müller glia in vivoJournal of Extracellular Vesicles, 2022
- System Xc− inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistanceCancer Letters, 2022
- Stimulating TRPM7 suppresses cancer cell proliferation and metastasis by inhibiting autophagyCancer Letters, 2022
- Hepatocyte TMEM16A Deletion Retards NAFLD Progression by Ameliorating Hepatic Glucose Metabolic DisorderAdvanced Science, 2020
- Platelet Function in Cardiovascular Disease: Activation of Molecules and Activation by MoleculesCardiovascular Toxicology, 2019
- Homozygous mutations in VAMP1 cause a presynaptic congenital myasthenic syndromeAnnals of Neurology, 2017
- Role of vesicle-associated membrane protein 2 in exocytosis of glucagon-like peptide-1 from the murine intestinal L cellDiabetologia, 2013
- The Hallmarks of AgingCell, 2013